Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice! More promos the more the word gets out, float gets eaten up and squeeze after squeeze:) Looks like you been anti ITUS from a dollar, hope you didn't get wiped out. Dangerous to short low floaters in a hot sector. Cancer, patents and AI:)
ITUS - 2 more Paid Promos today
ITUS Promoted by 2 Promoters with 14 Newsletters in last 5 days
Promoted Date Symbol Promoter Name Compensation
9/25/2017 ITUS OTC Tip Reporter To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure.
9/25/2017 ITUS Penny Stock Prophet None Listed or Image Compensation
9/24/2017 ITUS OTC Tip Reporter To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure.
9/24/2017 ITUS Penny Stock Prophet None Listed or Image Compensation
9/21/2017 ITUS OTC Tip Reporter To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure.
9/20/2017 ITUS OTC Tip Reporter To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure which has since expired.
9/20/2017 ITUS Penny Stock Prophet None Listed or Image Compensation
9/19/2017 ITUS OTC Tip Reporter To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure which has since expired.
9/19/2017 ITUS Penny Stock Prophet None Listed or Image Compensation
9/18/2017 ITUS OTC Tip Reporter To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure which has since expired.
9/18/2017 ITUS Penny Stock Prophet None Listed or Image Compensation
actually, no
there was only about a 592,200 short interest at the time of the run-up
my guess is that most of these 592,200 shares short were covered during the 20 million volume day and the other tens of millions of shares traded up to today
This is just simply the result of a well orchestrated massive paid stock promotion campaign, which is going to see one big drop to the below $1.00 stock price range in the coming weeks
Now this is what a squeeze looks like! I did tell folks last week to call their brokers to confirm the 'big short'...they have no shares to borrow!! Love it when those suckers get caught flat-footed!
Seems like déjà VJ of PULMination!
Now this is what a squeeze looks like! I did tell folks last week to call their brokers to confirm the 'big short'...they have no shares to borrow!! Love it when those suckers get caught flat-footed!
that is a completely 100% FASTE STATEMENT
as far as I am aware, ITUS is the only with awarded PATENTS!!!
as far as I am aware, ITUS is the only with awarded PATENTS!!!
8 Companies Developing Liquid Biopsy Cancer Tests
http://www.nanalyze.com/2016/01/8-companies-developing-liquid-biopsy-cancer-tests/
8 Blood Tests for Cancer Being Developed by Startups
http://www.nanalyze.com/2017/04/8-blood-tests-cancer/
Happy Bday! looks like you got a few nice bday gifts today:)
ITUS, a cancer-focused biotechnology company, through its wholly owned subsidiary, Anixa Diagnostics Corporation, is developing the CchekTM platform, a series of non-invasive blood tests for the early detection of solid tumor based cancers, which is based on the body's immunological response to the presence of a malignancy. ITUS also continually examines emerging technologies in complementary or related fields for further development and commercialization. Additional information is available at www.ITUScorp.com.
Just coming in from q b day Golf Game
Weeeee
Are Veritone and ITUS Corp. AI Pump and Dumps?
http://www.nanalyze.com/2017/09/veritone-itus-corp-ai-pump-dumps/
Weee wi!!
We'll get much more exposure there.
Super undervalued here!!
hello 3.08 and now we go to hmmmmmmmmmmm
the boys in the brite white sports car, raising their arms in the air!!
next stop 3.08
There she goes..huge breaK
ITUS - 2 more paid stock promotion newsletters sent out yesterday, Sept 24, 2017
ITUS Promoted by 2 Promoters with 12 Newsletters in last 5 days
Promoted Date Symbol Promoter Name Compensation
9/24/2017 ITUS OTC Tip Reporter To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure.
9/24/2017 ITUS Penny Stock Prophet None Listed or Image Compensation
9/21/2017 ITUS OTC Tip Reporter To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure.
9/20/2017 ITUS OTC Tip Reporter To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure which has since expired.
9/20/2017 ITUS Penny Stock Prophet None Listed or Image Compensation
9/19/2017 ITUS OTC Tip Reporter To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure which has since expired.
9/19/2017 ITUS Penny Stock Prophet None Listed or Image Compensation
9/18/2017 ITUS OTC Tip Reporter To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure which has since expired.
9/18/2017 ITUS Penny Stock Prophet None Listed or Image Compensation
lets see that 2.70 break and we are off
Last offering of $3.6M was around May 15, 2017.
Hopefully we're good for awhile, but i'm not worried, if offerings come, it'll be great time to snatch up more shares below $2.
Relax, it will be post on Internet matter or time. Itus looks strong only offering will bring it down!
No, I don't. I'm looking for that info too. Been searching the internet and didn't see anything.
Does anyone have info from the shareholder meeting?
I always worry about the possibility of dilutive measures ...anyone here have any concerns that they'll dilute by making more stock available?
No need to screaming a lot of promotions, just remember Itus' patent is all good for cancer patients. Lots potential I'd Itus products are real, not fake or misleading
ITUS = THE POWER of CANCER + AI + PATENTS = Explosive Move Going now $2.35 still super cheap, $20 coming!
Actually wrong. Tell Apple to stop marketing their products! Lol!
actually, wrong
there is a reason why ITUS has had several massive paid stock promotion campaigns in the last few months
simply, its the lack of future potential for the company
plain and simple
Promoted or not, this company just received patents in early Cancer detections using AI tech. It's in one of the hottest market right now.
Any small Artificial Intelligence company has very high chance get bought out. In addition to that, they have patents in CANCERs detections!
This stock is a KEEPER. With mkt cap ~ $30M - $35M right now, it will be 10-20X current value at least. IMO.
ITUS = PATENTS + AI + CANCER = $$ $BILLIONS$$$$
Promoted or not, this company just received patents in early Cancer detections using AI tech. It's in one of the hottest market right now.
Any small Artificial Intelligence company has very high chance get bought out. In addition to that, they have patents in CANCERs detections!
This stock is a KEEPER. With mkt cap ~ $30M - $35M right now, it will be 10-20X current value at least. IMO.
ITUS = PATENTS + AI + CANCER = $$$$BILLIONS$$$$
Yep, ITUS has been one of the most heavily promoted stocks of the week with 11 Newsletters sent out just this week
http://stockpromoters.com/View-Stock-Promotions-By-Symbol.aspx?symbol=itus&ctl00%24ContentPlaceHolderyy%24Footer1%24Image2.x=0&ctl00%24ContentPlaceHolderyy%24Footer1%24Image2.y=0
Reading Itus is promoted. any screenshots of newsletters available?
$6+ right around the corner.... shorts better cover or lose their shirts!
Will the investor meeting findings be released today or on monday? Eg. When will the findings affect the PPS?
He is talking about the SEC investigation rumors
What rumours are we talking about? :D :D :D I'm so excited!!!
What rumours are we talking about? :D :D :D I'm so excited!!!
Makes for a most excellent Friday! This one had a great week. Couple rumors swirling...we'll see.
Can anyone tell me when the shareholder meeting results will be released? I want to know when this thing is going to shoot for the sky!
So many runners today!!
There are enough shorts here from the week gone by to get us a very purty squeeze here today!! Call and ask your broker...they'll tell you.
All we need is for this volume sport to continue!
$ITUS
Followers
|
42
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
722
|
Created
|
06/05/06
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |